atropine has been researched along with disulfiram in 14 studies
Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) | Studies (disulfiram) | Trials (disulfiram) | Recent Studies (post-2010) (disulfiram) |
---|---|---|---|---|---|
26,711 | 1,259 | 1,697 | 3,776 | 175 | 723 |
Protein | Taxonomy | atropine (IC50) | disulfiram (IC50) |
---|---|---|---|
glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | Plasmodium berghei | 10.1 | |
Spike glycoprotein | Betacoronavirus England 1 | 9.35 | |
Replicase polyprotein 1ab | Betacoronavirus England 1 | 9.35 | |
type-1 angiotensin II receptor | Homo sapiens (human) | 6.637 | |
perilipin-5 | Homo sapiens (human) | 1.622 | |
perilipin-1 | Homo sapiens (human) | 6.959 | |
apelin receptor | Homo sapiens (human) | 2.63 | |
1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | Homo sapiens (human) | 4.2905 | |
bifunctional UDP-N-acetylglucosamine pyrophosphorylase/glucosamine-1-phosphate N-acetyltransferase | Mycobacterium tuberculosis H37Rv | 85.03 | |
Transmembrane protease serine 2 | Homo sapiens (human) | 9.35 | |
Bile salt export pump | Homo sapiens (human) | 10 | |
Carbamate kinase | Giardia intestinalis | 0.6 | |
Retinal dehydrogenase 1 | Homo sapiens (human) | 0.13 | |
Aldehyde dehydrogenase, mitochondrial | Homo sapiens (human) | 3.4 | |
Cytochrome P450 1A2 | Homo sapiens (human) | 4 | |
Procathepsin L | Homo sapiens (human) | 9.35 | |
Alpha-2A adrenergic receptor | Homo sapiens (human) | 4.904 | |
Fructose-1,6-bisphosphatase 1 | Homo sapiens (human) | 1.3756 | |
Replicase polyprotein 1a | Severe acute respiratory syndrome-related coronavirus | 9.35 | |
Replicase polyprotein 1ab | Human coronavirus 229E | 9.35 | |
Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | 9.35 | |
Adenosine receptor A3 | Homo sapiens (human) | 0.356 | |
Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 6.9171 | |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.356 | |
Alpha-2B adrenergic receptor | Homo sapiens (human) | 3.218 | |
D(1A) dopamine receptor | Homo sapiens (human) | 2.158 | |
D(4) dopamine receptor | Homo sapiens (human) | 3.15 | |
C-X-C chemokine receptor type 2 | Homo sapiens (human) | 6.013 | |
Mitogen-activated protein kinase 3 | Homo sapiens (human) | 1.51 | |
Protein-lysine 6-oxidase | Homo sapiens (human) | 0.32 | |
Lysine-specific demethylase 5A | Homo sapiens (human) | 10 | |
Caspase-1 | Homo sapiens (human) | 1.8 | |
Mu-type opioid receptor | Homo sapiens (human) | 3.511 | |
D(3) dopamine receptor | Homo sapiens (human) | 1.084 | |
Kappa-type opioid receptor | Homo sapiens (human) | 6.103 | |
C-C chemokine receptor type 2 | Homo sapiens (human) | 2.468 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.356 | |
C-C chemokine receptor type 4 | Homo sapiens (human) | 8.395 | |
Gasdermin-D | Homo sapiens (human) | 0.4 | |
Lysyl oxidase homolog 3 | Homo sapiens (human) | 0.093 | |
Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | 9.35 | |
Sodium-dependent dopamine transporter | Homo sapiens (human) | 4.637 | |
NACHT, LRR and PYD domains-containing protein 3 | Mus musculus (house mouse) | 3 | |
Lysyl oxidase homolog 4 | Homo sapiens (human) | 0.059 | |
Histone-lysine N-methyltransferase EHMT2 | Homo sapiens (human) | 0.6 | |
Monoglyceride lipase | Homo sapiens (human) | 0.8095 | |
Angiotensin-converting enzyme 2 | Homo sapiens (human) | 9.35 | |
Gasdermin-D | Mus musculus (house mouse) | 0.4 | |
Histone-lysine N-methyltransferase EHMT1 | Homo sapiens (human) | 1.6 | |
Lysyl oxidase homolog 2 | Homo sapiens (human) | 0.15 | |
large T antigen | Betapolyomavirus macacae | 10.73 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (42.86) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (7.14) | 29.6817 |
2010's | 7 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Chilian, WM; Lake, DA; Roberts, LA | 1 |
Stoliarov, GV | 1 |
Day, MD; Hall, JM; Owen, DA | 1 |
Koe, BK; Weissman, A | 1 |
Rosenblum, G; Rosenblum, I | 1 |
Sourkes, TL; Widy-Tyszkiewicz, E | 1 |
1 review(s) available for atropine and disulfiram
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
13 other study(ies) available for atropine and disulfiram
Article | Year |
---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Ethanol increases rate of isolated atria.
Topics: Animals; Atropine; Disulfiram; Drug Interactions; Ethanol; Female; Heart Rate; In Vitro Techniques; Male; Myocardial Contraction; Propranolol; Pyrazoles; Rabbits; Time Factors | 1978 |
[On the course of drug psychoses].
Topics: Adrenocorticotropic Hormone; Adult; Atropine; Barbiturates; Chlorpromazine; Disulfiram; Drug Hypersensitivity; Female; Humans; Isoniazid; Male; Prednisolone; Psychoses, Substance-Induced; Quinacrine; Time Factors | 1968 |
Selective inhibition of angiotensin pressor responses in the pithed rat by tetraethylthiuram disulphide (disulfiram) and sodium diethyldithiocarbamate (DDC).
Topics: Angiotensin II; Animals; Ascorbic Acid; Atropine; Blood Pressure; Disulfiram; Dose-Response Relationship, Drug; Drug Synergism; Electric Stimulation; Heart Rate; Male; Norepinephrine; Penicillamine; Rats; Reserpine; Sympathetic Nervous System; Thiocarbamates; Tubocurarine; Vasopressins | 1972 |
m-Fluorotyrosine convulsions and mortality: relationship to catecholamine and citrate metabolism.
Topics: 5-Hydroxytryptophan; Amphetamine; Animals; Anticonvulsants; Atropine; Azoles; Brain; Chlordiazepoxide; Chlorpromazine; Citrates; Dihydroxyphenylalanine; Disulfiram; Drug Antagonism; Drug Synergism; Kidney; Lysergic Acid Diethylamide; Male; Methyldopa; Mice; Morphine; Nialamide; Norepinephrine; Pargyline; Phenobarbital; Phenytoin; Reserpine; Seizures; Serotonin; Strychnine; Tetrabenazine; Trimethadione; Tyrosine; Urea | 1967 |
Effect of drugs and chemicals on subcellular organelles: mitochondrial shrinking and autonomic agents.
Topics: Adenosine Triphosphate; Animals; Atropine; Disulfiram; Electric Stimulation; Heart; In Vitro Techniques; Iproniazid; Mitochondria; Mitochondria, Muscle; Myocardium; Norepinephrine; Propranolol; Rabbits; Reserpine; Vagus Nerve | 1969 |
n-Pentylamine: effect on motor activity of mice.
Topics: Amines; Animals; Antipsychotic Agents; Atropine; Disulfiram; Fenclonine; Kinetics; Male; Methyltyrosines; Mice; Motor Activity; Phenoxybenzamine; Reserpine | 1980 |